Pfizer (NYSE:PFE) develops and sells biopharmaceutical products, including vaccines, treatments for infectious diseases, ...

Pfizer Inc. raised its profit forecast for the year, with the drugmaker’s ongoing cost cuts helping to make up for a lack of ...

Pfizer Inc. (NYSE:PFE) will release earnings results for the second quarter before the opening bell on Tuesday, Aug. 5.

CAMBRIDGE, MA / ACCESS Newswire / August 1, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the UK Court of Appeal ...

Pfizer (PFE) reported a beat in second quarter earnings Tuesday, and reaffirmed its 2025 revenue guidance of $61 billion to ...

Pfizer (PFE) stock is rising after the company reported strong second-quarter earnings and lifted its full-year forecast ...

Pfizer CEO Albert Bourla is expected at a pro-Trump fundraiser on Friday, sources told CBS News, one day after the president ...

For many investors, the main point of stock picking is to generate higher returns than the overall market. But in ...

Intervention/Treatment: The study tested PF-07275315, an experimental drug administered as a single intravenous infusion. The purpose was to evaluate its safety profile and how it behaves in the body ...

(PFE) on Tuesday reported second-quarter net income of $2.91 billion. The New York-based company said it had profit of 51 cents per share.

BUCHAREST, ROMANIA - Media OutReach Newswire - 6 August 2025 - Pfizer Romania has been officially certified as one of the ...